Dr Nadine Wehida
Faculties, deparments and locations
- Faculty of Health, Science, Social Care and Education
- Department of Biomolecular Sciences
- School of Life Sciences, Pharmacy and Chemistry
- Penrhyn Road
Lecturer in Genetics and Molecular Biology
- Email:
- n.wehida@kingston.ac.uk
About
After having completed my Bachelor's degree in Pharmacy from Alexandria University, Egypt in 2011, I went on to achieve my Master's degree (2017) in Clinical Biochemistry before successfully completing my PhD (2021) specialising in Biochemistry from the Medical Research Institute, Alexandria University in Egypt.
I began my academic career at Pharos University in Alexandria, Egypt in 2011, where I taught several levels and various modules to Pharmacy undergraduate students. During my career in academia I have led several modules including Medicinal chemistry, Cell Biology and Biochemistry. In terms of leadership, I was appointed quality assurance coordinator of the Chemistry department and was a part of the 'Teaching Programs' Quality Assurance Unit.
I was appointed Lecturer in Genetics and Molecular Biology at Kingston University London in 2022, where I obtained a Fellowship of the Higher Education Academy in July 2023. I was appointed deputy course leader of both BSc Biochemistry and Biological Sciences in September 2023.
My research interest is primarily cancer biology. I have previously worked with cancer patients at the Medical Research Institute in Alexandria, Egypt between 2012-2021, where I studied various aspects of disease progression ranging from oxidative status of the tumour, the genomics involved in the onset of the disease and finally its clinicopathological status.
Qualifications
- 2011- BSc (Hons) in Pharmacy
- MSc in Clinical Biochemistry
- PhD in Biochemistry
- FHEA
Domains
My research interest is primarily cancer biology. I have previously worked with cancer patients at the Medical Research Institute in Alexandria, Egypt between 2012-2021, where I studied various aspects of disease progression ranging from oxidative status of the tumour, the genomics involved in the onset of the disease and finally its clinicopathological status. I am currently studying the repurposing of several drugs to be employed in a number cancer models and I am actively collaborating with cancer biologists in this process.
I will begin my research group at Kingston University in October 2023 with a Masters by Research in drug repurposing and a PhD as part of a collaboration on the same topic.
Module leader of LS5001- Molecular Biology of the Cell
Deputy course leader of Biochemistry and Biological Sciences